학술논문
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer - Immun-HER trial (GOIRC-01-2016)
Document Type
Article
Author
Pellegrino, B.; Tommasi, C.; Campanini, N.; Silini, E.M.; Musolino, A.; Serra, O.; Gori, S.; Cretella, E.; Ambroggi, M.; Frassoldati, A.; Bisagni, G.; Casarini, C.; Bria, E.; Carbognin, L.; Fiorio, E.; Mura, A.; Zamagni, C.; Gianni, L.; Zambelli, A.; Montemurro, F.; Tognetto, M.; Todeschini, R.; Missale, G.; Maglietta, G.
Source
In: Journal for ImmunoTherapy of Cancer . (Journal for ImmunoTherapy of Cancer, 28 November 2023, 11(11))
Subject
Language
English
ISSN
20511426